SGS Life Science Services - - BioPharm International


SGS Life Science Services

BioPharm International
Volume 19, Issue 12

Company Description

SGS is a verification testing, inspection, and certification company. SGS Life Science Services is a contract service organization providing clinical research services and quality control testing. We serve a variety of Life Science companies including pharmaceutical, biopharmaceutical, biotechnology and medical device manufacturers. SGS provides clinical trial management (Phase 1 to 4) and services encompassing bioequivalence studies, bioanalytical services, data management, biometrics and regulatory consultancy. Our quality control services (detailed below) complete our portfolio by offering analytical chemistry, microbiology, and toxicology tests that meet regulatory compliance.

Biopharmaceutical Techniques Supported

  • Cell Line Characterization
  • Host Cell Impurity Testing
  • Mycoplasma Testing
  • Protein Analysis

Markets Served

SGS operates a global network of quality control testing laboratories with facilities in the USA, Canada, Belgium, France, Germany, India, Hong Kong, China, South Korea, Taiwan, Thailand and Singapore.

Products and Services

  • Quality control testing of raw materials, APIs and finished products
  • Monograph testing (USP, EP, BP, JP)
  • Analytical method development and validation
  • Container testing
  • Environmental testing
  • Inspection services
  • Medical device testing
  • Microbiological testing
  • Safety testing (in vivo, in vitro)
  • Stability testing according to ICH guidelines or customer specifications
  • Toxicology
  • Water System Validation


In North America, SGS has facilities in Northbrook, IL, Fairfield, NJ, Spartanburg, SC, and Mississauga, ON. Our quality control laboratories operate according to the highest quality standards (cGMP, GLP, ISO 17025) and have been inspected by the FDA or local regulatory authorities.

75 Passaic Avenue
Fairfield NJ 07004



1,300 (USA)
43,000 (worldwide)


blog comments powered by Disqus



Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here